Mankind Pharma Profit Up 10% to Rs 543 cr in Q1 FY25

Jul 31, 2024 17:32

Mankind Pharma's consolidated profit after tax rose 10% YoY to Rs 543 crore in the April-June quarter, driven by increased revenue. Read more.

Photograph: Courtesy, Mankind Pharma

New Delhi, Jul 31 (PTI) Mankind Pharma on Wednesday said its consolidated profit after tax increased by 10 per cent year on year to Rs 543 crore in the quarter ended on June 30, 2024.

The drug firm had reported a profit after tax of Rs 494 crore in the April-June quarter of the previous fiscal.

Revenue from operations rose to Rs 2,893 crore in the period under review from Rs 2,579 crore in the year-ago period, Mankind Pharma said in a statement.

Shares of the company on Wednesday ended 1.21 per cent down at Rs 2,031.15 apiece on the BSE.

Source: PTI

MORE NEWS

Unilever: India Growth & GST Impact

Unilever sees huge opportunities in India due to high GDP growth and GST cuts. HUL...

Trai Recommends 6 GHz, E, V Band Allocation

Trai suggests administrative allocation of 6 GHz, E, and V bands for telecom backhaul....

TotalEnergies Sells Stake in Adani Green Energy

TotalEnergies sells 1.74% stake in Adani Green Energy for Rs 2,778 cr. Stake reduced to...

TCS Acquires Coastal Cloud for $700 Million

TCS acquires Coastal Cloud for USD 700 million, strengthening its Salesforce and AI...

JSW Paints Acquires AkzoNobel India Stake

JSW Paints completes acquisition of majority stake in AkzoNobel India, becoming the...

Park Medi World IPO Subscribed 52% on Day 1

Park Medi World''s IPO received 52% subscription on day 1. The Rs 920-crore IPO closes...

Dasnac Invests Rs 2,000 Cr in Noida Luxury Housing

Dasnac to invest Rs 2,000 crore in a luxury housing project, Dasnac Westminster, in...

Nephrocare IPO Subscribed 12% on Day 1

Nephrocare Health Services IPO received 12% subscription on day 1. IPO details, price...

Wakefit IPO Subscribed Over 2 Times

Wakefit''s Rs 1,289-cr IPO was subscribed over 2 times on the final day. Details on...

IAN Group to Deploy USD 100M Alpha Fund by 2027

IAN Group to deploy its USD 100 million IAN Alpha Fund in early-stage startups by 2027....

Mankind Pharma Profit Up 10% to Rs 543 cr in Q1 FY25

You May Like To Read

MORE NEWS